
|Articles|March 28, 2022
Summary of SMFM Consult Series #58: Use of antenatal corticosteroids for individuals at risk for late preterm delivery
This Consult has been endorsed by the American College of Obstetricians and Gynecologists (ACOG) and replaces the Society for Maternal-Fetal Medicine's (SMFM) Statement #4, Implementation of the use of antenatal corticosteroids in the late preterm birth period in women at risk for preterm delivery, August 2016.
Advertisement
This Consult originally appeared in the American Journal of Obstetrics and Gynecology in November 2021.
Check out the Visual Summary below or download it as a PDF.
Advertisement
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
HIV screening, PrEP counseling get stronger ACOG recommendation
2
Telehealth expands maternal-fetal medicine access, with Jeffrey Chapa, MD
3
Updated: CMS proposed G-codes for obstetric billing draw concern from ACOG amid coding transition
4
Biomarker testing for preeclampsia with Lisa A. Bukovac, DO, FACOG
5





